Fusion PharmaceuticalsI Valuation

FUSN Stock  USD 21.32  0.02  0.09%   
At this time, the firm appears to be overvalued. Fusion PharmaceuticalsInc shows a prevailing Real Value of $18.97 per share. The current price of the firm is $21.32. Our model computes the value of Fusion PharmaceuticalsInc from reviewing the firm fundamentals such as Operating Margin of (47.98) %, shares owned by insiders of 4.41 %, and Shares Outstanding of 84.69 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Price Book
8.1122
Enterprise Value
1.6 B
Enterprise Value Ebitda
(18.51)
Price Sales
873.1365
Enterprise Value Revenue
784.1011
Overvalued
Today
21.32
Please note that Fusion PharmaceuticalsI's price fluctuation is moderately volatile at this time. Calculation of the real value of Fusion PharmaceuticalsInc is based on 3 months time horizon. Increasing Fusion PharmaceuticalsI's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Fusion PharmaceuticalsInc is useful when determining the fair value of the Fusion stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Fusion PharmaceuticalsI. Since Fusion PharmaceuticalsI is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fusion Stock. However, Fusion PharmaceuticalsI's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  21.32 Real  18.97 Target  13.1 Hype  21.32 Naive  26.12
The real value of Fusion Stock, also known as its intrinsic value, is the underlying worth of Fusion PharmaceuticalsInc Company, which is reflected in its stock price. It is based on Fusion PharmaceuticalsI's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Fusion PharmaceuticalsI's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fusion PharmaceuticalsI's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
18.97
Real Value
32.29
Upside
Estimating the potential upside or downside of Fusion PharmaceuticalsInc helps investors to forecast how Fusion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fusion PharmaceuticalsI more accurately as focusing exclusively on Fusion PharmaceuticalsI's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-0.39-0.36-0.34
Details
Hype
Prediction
LowEstimatedHigh
8.0021.3234.64
Details
Naive
Forecast
LowNext ValueHigh
12.7926.1239.44
Details
12 Analysts
Consensus
LowTarget PriceHigh
11.9213.1014.54
Details

Fusion PharmaceuticalsI Investments

(76.43 Million)

Fusion PharmaceuticalsI Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Fusion PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare Fusion PharmaceuticalsI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fusion PharmaceuticalsI competition to find correlations between indicators driving Fusion PharmaceuticalsI's intrinsic value. More Info.
Fusion PharmaceuticalsInc is one of the top stocks in price to sales category among related companies. It is rated # 2 in price to book category among related companies fabricating about  0.01  of Price To Book per Price To Sales. The ratio of Price To Sales to Price To Book for Fusion PharmaceuticalsInc is roughly  107.63 . As of the 29th of March 2024, Price To Book Ratio is likely to grow to 2.98. Comparative valuation analysis is a catch-all model that can be used if you cannot value Fusion PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fusion PharmaceuticalsI's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fusion PharmaceuticalsI's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Fusion PharmaceuticalsI's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Fusion PharmaceuticalsI and how it compares across the competition.

About Fusion PharmaceuticalsI Valuation

The stock valuation mechanism determines the current worth of Fusion PharmaceuticalsInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Fusion PharmaceuticalsInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Fusion PharmaceuticalsInc based exclusively on its fundamental and basic technical indicators. By analyzing Fusion PharmaceuticalsI's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Fusion PharmaceuticalsI's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fusion PharmaceuticalsI. We calculate exposure to Fusion PharmaceuticalsI's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Fusion PharmaceuticalsI's related companies.
Last ReportedProjected for 2024
Gross Profit723 K759.1 K
Pretax Profit Margin(45.51)(47.78)
Operating Profit Margin(47.98)(50.38)
Net Loss(45.89)(48.18)
Gross Profit Margin 0.35  0.37 

8 Steps to conduct Fusion PharmaceuticalsI's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fusion PharmaceuticalsI's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fusion PharmaceuticalsI's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Fusion PharmaceuticalsI's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Fusion PharmaceuticalsI's revenue streams: Identify Fusion PharmaceuticalsI's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Fusion PharmaceuticalsI's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Fusion PharmaceuticalsI's growth potential: Evaluate Fusion PharmaceuticalsI's management, business model, and growth potential.
  • Determine Fusion PharmaceuticalsI's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fusion PharmaceuticalsI's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Fusion PharmaceuticalsI Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Fusion PharmaceuticalsI does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding65.6 M

Fusion PharmaceuticalsI Current Valuation Indicators

Valuation refers to the process of determining the present value of Fusion PharmaceuticalsInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Fusion we look at many different elements of the entity such as Fusion's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Fusion PharmaceuticalsI's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Fusion PharmaceuticalsI's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Fusion PharmaceuticalsI, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Fusion PharmaceuticalsI's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Fusion PharmaceuticalsI's worth.
When determining whether Fusion PharmaceuticalsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fusion PharmaceuticalsI's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fusion Pharmaceuticalsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fusion Pharmaceuticalsinc Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fusion PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Fusion Stock analysis

When running Fusion PharmaceuticalsI's price analysis, check to measure Fusion PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fusion PharmaceuticalsI is operating at the current time. Most of Fusion PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Fusion PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fusion PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Fusion PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Fusion PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fusion PharmaceuticalsI. If investors know Fusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fusion PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.45)
Revenue Per Share
0.032
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.25)
Return On Equity
(0.49)
The market value of Fusion PharmaceuticalsInc is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Fusion PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fusion PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Fusion PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fusion PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.